Veradermics, Incorporated
MANENYSEHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $5.61B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $32.00$136.72
- Volume (live)
- -
- Avg. volume (3M)
- 880.15K
Veradermics, Incorporated (MANE) Stock Price & Financial Analysis
Veradermics, Incorporated Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $134.49 - $139.93 |
|---|---|
| 52-Week High | $136.72 |
| 52-Week Low | $32.00 |
| Open | $139.44 |
| Volume (last close) | 426.41K |
| Average Volume (3M) | 880.15K |
| 50-Day MA | $109.75 |
|---|
| Market Cap | 5.61B |
|---|---|
| Shares Outstanding | 40.44M |
| Price to Book (P/B) | 6.90 |
| EV/EBITDA | -54.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Veradermics, Incorporated at a Glance
As of the Oct 23, 2026 close, Veradermics, Incorporated (MANE) has a market capitalization of $5.61B.
As of its latest reported balance sheet, it holds $319.33M in cash and securities against $428.00K of debt, a net cash position of $318.90M.
Veradermics, Incorporated does not currently pay a dividend.
At $138.78 (the Oct 23, 2026 close) it sits near the top of its 52-week range of $32.00 to $136.72.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $169.00, 21.8% above the Oct 23, 2026 close.
Frequently Asked Questions About Veradermics, Incorporated
What is the current stock price for MANE?
As of the Oct 23, 2026 close, MANE stock trades at $138.78. The 52-week range is $32.00–$136.72, with a day range of $134.49–$139.93.
What is the P/E ratio for MANE?
The P/E ratio (Price-to-Earnings) for MANE is shown in the Key Statistics section. This valuation metric helps compare Veradermics, Incorporated to industry peers.
Does MANE pay dividends?
Veradermics, Incorporated does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for MANE?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for MANE is Buy. The average 12-month price target is $169.00, a 21.8% upside from the Oct 23, 2026 close of $138.78.
What is the market cap of MANE?
As of the Oct 23, 2026 close, Veradermics, Incorporated's market capitalization is $5.61B, classifying it as a mid-cap company. Veradermics, Incorporated operates in the Healthcare sector within the Biotechnology industry.